A Prospective, Multicenter, Randomized Controlled Study on the Efficacy and Safety of Low-dose Carboplatin Combined With Nab-Paclitaxel and Delayed Administration of Serplulimab as First-line Treatment for Advanced Squamous Non-small Cell Lung Cancer
Clinical trial NCT07647094 · RECRUITING
Trial details
- NCT number
- NCT07647094
- Sponsor
- People's Hospital of Quzhou
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-10-31
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.